MIAMI, FL –The National Center for Advancing Translational Sciences and the National Institute of Neurological Disorders and Stroke have granted a $6.24 million cooperative agreement award to Dr. Michael Benatar for the establishment of a Rare Diseases Clinical Research Consortium. The consortium, to be called CReATe (Clinical Research in ALS and related disorders for Therapeutic development) will study amyotrophic lateral sclerosis (ALS) and other related rare diseases.
This unique collaborative effort will attempt to elucidate the relationship between phenotype and genotype in ALS and related disorders, search for new genetic causes of disease, identify genetic modifiers, and the development of biomarkers that may aid in therapy development.
For more details, please view the articles below.
- University of Miami News: NIH Grants $6.24 Million Cooperative Agreement to University of Miami Neurologist
- NIH Press Release